Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27919 | 179 | 37.8 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1193 | 8854 | CYCLOPROPANES//DIAZO COMPOUNDS//IROFULVEN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IROFULVEN | Author keyword | 67 | 89% | 17% | 31 |
2 | MGI 114 | Author keyword | 57 | 95% | 11% | 19 |
3 | HMAF | Author keyword | 38 | 93% | 8% | 14 |
4 | ILLUDINS | Author keyword | 21 | 85% | 6% | 11 |
5 | 6 HYDROXYMETHYLACYLFULVENE | Author keyword | 17 | 100% | 4% | 8 |
6 | ILLUDIN S | Author keyword | 15 | 82% | 5% | 9 |
7 | ACYLFULVENE | Author keyword | 14 | 100% | 4% | 7 |
8 | ILLUDIN | Author keyword | 12 | 86% | 3% | 6 |
9 | OMPHALOTUS ILLUDENS | Author keyword | 3 | 100% | 2% | 3 |
10 | DIFFERENTIAL APOPTOSIS | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IROFULVEN | 67 | 89% | 17% | 31 | Search IROFULVEN | Search IROFULVEN |
2 | MGI 114 | 57 | 95% | 11% | 19 | Search MGI+114 | Search MGI+114 |
3 | HMAF | 38 | 93% | 8% | 14 | Search HMAF | Search HMAF |
4 | ILLUDINS | 21 | 85% | 6% | 11 | Search ILLUDINS | Search ILLUDINS |
5 | 6 HYDROXYMETHYLACYLFULVENE | 17 | 100% | 4% | 8 | Search 6+HYDROXYMETHYLACYLFULVENE | Search 6+HYDROXYMETHYLACYLFULVENE |
6 | ILLUDIN S | 15 | 82% | 5% | 9 | Search ILLUDIN+S | Search ILLUDIN+S |
7 | ACYLFULVENE | 14 | 100% | 4% | 7 | Search ACYLFULVENE | Search ACYLFULVENE |
8 | ILLUDIN | 12 | 86% | 3% | 6 | Search ILLUDIN | Search ILLUDIN |
9 | OMPHALOTUS ILLUDENS | 3 | 100% | 2% | 3 | Search OMPHALOTUS+ILLUDENS | Search OMPHALOTUS+ILLUDENS |
10 | DIFFERENTIAL APOPTOSIS | 1 | 100% | 1% | 2 | Search DIFFERENTIAL+APOPTOSIS | Search DIFFERENTIAL+APOPTOSIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRADITIONAL ANTICANCER AGENTS | 80 | 100% | 14% | 25 |
2 | LUNG CARCINOMA XENOGRAFT | 77 | 96% | 13% | 24 |
3 | ILLUDIN S | 56 | 75% | 23% | 41 |
4 | MGI 114 | 55 | 92% | 12% | 22 |
5 | 6 HYDROXYMETHYLACYLFULVENE | 47 | 86% | 13% | 24 |
6 | HYDROXYMETHYLACYLFULVENE HMAF | 44 | 88% | 12% | 21 |
7 | HMAF | 29 | 88% | 8% | 14 |
8 | MGI 114 HMAF | 23 | 100% | 6% | 10 |
9 | MGI 114 6 HYDROXYMETHYLACYLFULVENE | 17 | 100% | 4% | 8 |
10 | ILLUDINS | 14 | 57% | 9% | 17 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Anticancer Active Illudins: Recent Developments of a Potent Alkylating Compound Class | 2011 | 12 | 76 | 79% |
Enantioselective Total Synthesis of (-)-Acylfulvene and (-)-Irofulven | 2009 | 23 | 88 | 38% |
Chemistry and Biology of Acylfulvenes: Sesquiterpene-Derived Antitumor Agents | 2012 | 10 | 225 | 38% |
ATM-dependent CHK2 activation induced by anticancer agent, irofulven | 2004 | 29 | 104 | 18% |
News about... the proteasome inhibitor PS341 | 2002 | 8 | 3 | 33% |
Fungal genetics, genomics, and secondary metabolites in pharmaceutical sciences | 2007 | 19 | 84 | 12% |
Perspectives on the oncologist pharmacopceia | 2003 | 2 | 28 | 21% |
Novel treatments and therapies in development for pancreatic cancer | 2002 | 10 | 105 | 4% |
Gateways to clinical trials | 2004 | 0 | 19 | 5% |
Gateways to clinical trials | 2004 | 4 | 28 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOL 8320 | 1 | 100% | 1.1% | 2 |
2 | CANC CELL BIOL BRANCH | 1 | 33% | 1.1% | 2 |
3 | DRUG DESIGN MOL MED | 1 | 50% | 0.6% | 1 |
4 | BIOL PHARMACOGENET HUMAN TUMORS | 0 | 33% | 0.6% | 1 |
5 | EQUIPE ACCUEIL 3535 | 0 | 33% | 0.6% | 1 |
6 | PHARMACEUT SCI PHARMACEUT BIOL BIOTECHNOL | 0 | 33% | 0.6% | 1 |
7 | SIGNALISAT | 0 | 33% | 0.6% | 1 |
8 | FED RECH 54 | 0 | 20% | 0.6% | 1 |
9 | GRP BIOL PHARMACOGENET HUMAN TUMORS | 0 | 20% | 0.6% | 1 |
10 | KANAGAWA S | 0 | 20% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000185648 | PROTOILLUDANE//LACTARIUS VELLEREUS//GLOEOPHYLLUM ABIETINUM |
2 | 0.0000126290 | PTAQUILOSIDE//BRACKEN FERN//BOVINE ENZOOTIC HEMATURIA |
3 | 0.0000086806 | LIPPIA INTEGRIFOLIA//ARGONNE ADV PHOTON SOURCE//CYCLOPROPYLCARBINOLS |
4 | 0.0000085016 | DUOCARMYCINS//CC 1065//DUOCARMYCIN |
5 | 0.0000077287 | PARAMAGNETIC SILICA BASED MATERIALS//PSEUDOHALOGENATION//PSEUDOHALOPHOSPHATES |
6 | 0.0000072533 | VINYLIDENECYCLOPROPANES//BICYCLOPROPYLIDENE//METHYLENECYCLOPROPANE |
7 | 0.0000071887 | CS 670//LOXOPROFEN//ALPHA BETA KETOALKENE |
8 | 0.0000065737 | SPIROHETEROCYCLES//CYCLOALKYLIDENEPYRAZOLINONES//IMINO PIPERIDINE |
9 | 0.0000063568 | PULVINIC ACIDS//ALBATRELLUS CONFLUENS//VIALININ A |
10 | 0.0000049437 | GUANACASTEPENE//DICTYOTACEAE//DOLASTANES |